Cocrystal Pharma
COCP
$1.90
Share price
-4.04%
Change (1 day)
-60.42%
Change (1 year)
Categories
Revenue for Cocrystal Pharma (COCP)
Revenue in 2023 (TTM): N/A
In 2022 the company made a revenue of N/A a decrease over the years 2021 revenue that were of N/A.The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.
Revenue history for Cocrystal Pharma from 2009 to 2023
Annual revenue
| Year | Revenue | Change |
|---|---|---|
| 2023 (TTM) | N/A | |
| 2022 | N/A | |
| 2021 | N/A | -100% |
| 2020 | $2.01 M | -69.32% |
| 2019 | $6.56 M | |
| 2018 | N/A | |
| 2017 | N/A | |
| 2016 | N/A | -100% |
| 2015 | $0.07 M | 766.67% |
| 2014 | $0 M | -97.08% |
| 2013 | $0.3 M | -98.21% |
| 2012 | $17.19 M | 69.05% |
| 2011 | $10.16 M | |
| 2010 | N/A | |
| 2009 | N/A |
Revenue for similar companies or competitors
| Company | Revenue | Revenue differencediff. | Country |
|---|---|---|---|
 Johnson & Johnson JNJ | $93.76 B | N/A | 🇺🇸 USA |
 Merck MRK | $58.31 B | N/A | 🇺🇸 USA |
 Nature's Sunshine Products NATR | $0.43 B | N/A | 🇺🇸 USA |
 USANA USNA | $0.94 B | N/A | 🇺🇸 USA |